Olema Oncology Statistics
NASDAQ: OLMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.02-0.13 (-1.82%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Olema Oncology by the numbers
Olema Oncology has a market capitalization of $615.0 million based on 87.61M shares outstanding. With trailing EPS of $-2.40, Olema Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.5% below its 50-day average and 44.4% below its 200-day average.
Average daily trading volume is 1.27M shares, or about $8.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OLMA valuation vs. peer median
| Metric | OLMA | Peer median | Difference |
|---|---|---|---|
| Market cap | $615.00M | $625.81M | -2% |
| Avg. volume | 1.27M | 1.34M | -5% |
Peer median across 8 companies: KURA, JANX, ABUS, SGMT, ANNX, NVCT, IMMX, APMD.
Valuation
- Market cap
- $615.00M
- EPS (TTM)
- $-2.40
- Shares outstanding
- 87.61M
Price and trading
- Previous close
- 7.15
- Open
- 7.01
- Day range
- 6.88 – 7.35
- 52-week range
- 6.24 – 36.26
- 52-week change
- -69.70%
- Beta
- —
- Volume
- 1.26M
- Average volume
- 1.27M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 615.00M
- Forward Pe
- -2.42
- Eps
- -2.40
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 36.26
- Week52 Low
- 6.24
- Avg Volume
- 1.27M
- Shares Outstanding
- 87.61M
- Ma50
- 7.84
- Ma200
- 12.62
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -80.64%
- Pct From52w Low
- 12.59%